about
Hairpin structure within the 3'UTR of DNA polymerase beta mRNA acts as a post-transcriptional regulatory element and interacts with Hax-1Evaluation of prognostic significance of circulating tumor cells detection in rectal cancer patients treated with preoperative radiotherapy: prospectively collected material data.HAX-1 overexpression, splicing and cellular localization in tumors.EGFR, PIK3CA, KRAS and BRAF mutations in meningiomasMolecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.Regulatory functions of 3'UTRs.PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting.Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.Promoter methylation and expression levels of selected hematopoietic genes in pediatric B-cell acute lymphoblastic leukemia.Developments in targeted therapy of advanced gastrointestinal stromal tumors.What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia.The Role of SWI/SNF Chromatin Remodeling Complexes in Hormone Crosstalk.HAX-1 is a nucleocytoplasmic shuttling protein with a possible role in mRNA processing.Characterization of a prokaryotic topoisomerase I activity in chloroplast extracts from spinachLevels and size complexity of DNA polymerase beta mRNA in rat regenerating liver and other organs.Expression changes of cell-cell adhesion-related genes in colorectal tumors.Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy.Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.Inhibition of calf thymus DNA polymerase alpha and of normal and cancer cell growth by butylanilinouracil and butylphenylguanine.The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma.Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features.The frequency of human papillomavirus infection in polish patients with vulvar squamous cell carcinoma.Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.Myocardial Expression of PPARγ and Exercise Capacity in Patients after Coronary Artery Bypass Surgery.Changes in the DNA polymerase beta gene expression during development of lung, brain, and testis suggest an involvement of the enzyme in DNA recombination.DNA methylation profiling in nonfunctioning pituitary adenomas.Downregulation of PTPRH (Sap-1) in colorectal tumors.Active transport of RB protein from the nucleus to the cytoplasm as one of the development mechanisms of HER2-positive breast cancer.Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype.Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).Lack of microsatellite instability in squamous cell vulvar carcinoma.[AMP-activated protein kinase (AMPK) as therapeutic target].Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.Prognostic value of multiple reverse transcription-PCR tyrosinase testing for circulating neoplastic cells in malignant melanoma.Advanced adenoid cystic carcinoma (ACC) is featured by SWI/SNF chromatin remodeling complex aberrationsThe Outcome of Targeted Therapy in Advanced Gastrointestinal Stromal Tumors (Gist) with Non-Exon 11 Kit Mutations
P50
Q24565017-4875B2E6-F6A7-41C1-94DF-9542BF9FC8EBQ30835735-CB289260-C33A-4665-B8A3-A5C8408AD6CFQ33536132-41CA50A5-B6C4-47BD-8C21-278431076EF1Q33727426-21B4E27E-7280-4166-B0E6-02AD88DBD125Q33778554-775FADC1-9151-42C3-9F7C-B06EE9C13546Q34404957-E0CBBF1A-3D16-4E84-852C-C36D73E53B5BQ34412608-C9D212F3-90B3-4849-8D46-8F94E5496A29Q34446657-F935182A-793A-49D8-83BA-AE7E50724A1DQ35226606-E68241FC-ECAB-4B19-B6A7-5C73C9161A19Q37185326-9F15330A-0A64-46AF-A167-42F082B7F96AQ37342226-9CF90B99-D7BC-4823-9454-57F3BF8B8C34Q37427414-522C0439-1294-4EDC-A7F0-C7A05343B167Q38628904-1363D9C6-847A-4C5F-846B-CCB96237FF31Q38752288-F64D2280-8E89-48C0-8919-A8775A5C909BQ39242535-EE67FE29-F36B-47D6-9B86-48DE7A2C69C0Q40490560-A7FE409B-6390-4A2F-B8EB-B6A7D5C9B8D2Q41778975-73AB2413-B16D-462B-A518-61B6EB1703AEQ41817645-D8942D0A-1E6C-45C9-9C7C-99513CE3FEADQ41918438-F2E9A4E0-03D9-4D22-B7B6-F81B029D83ACQ42175088-2C30A9E4-46D3-42A7-9B8E-346277C4769FQ42256841-F1B33381-68B9-49DB-8E8B-D0DC1827FAE6Q43239380-AE78B36B-5EDA-4A7B-BE9E-70CE271DC81EQ43474613-C2A331DD-DF31-4FFD-BF22-3AA767FF9FF2Q44031590-40BA4EE7-E59F-46B3-9C74-FFCBAFC2397AQ44394114-3E7F0910-51B2-47DB-95DD-48730A23D74FQ44565703-44A196C0-E4FE-43C0-9445-42F93ED7BF57Q46491077-95839943-14E2-4278-96CD-5254E447E7C6Q47152359-68A92660-A5AA-4AD4-95C2-CBEA6D67C78BQ48867838-10EDC435-72B6-4B61-93E4-E4760388D322Q50151801-2E6E481B-A846-443B-BC9D-844CE4DF015FQ50887398-7BC7AF01-B7A5-4504-91C7-6C2D6BD89851Q51033924-67C1504E-94DA-45D4-9EAA-231A7A1D7972Q51378067-CD45635B-20CA-4255-9480-77D93C8FDEE1Q53135694-0223EDA9-14AD-4C2C-8017-B4A8F87A1837Q53278316-9ECD3C87-995F-4139-84BE-9298E6FB78E5Q54410270-985FD665-4DD8-4B6E-A330-60CC43961677Q54694599-474F3863-158C-42F2-8BD0-048C034EA0DEQ54759572-852E3C58-F603-440E-85CD-662D6320AD55Q58088602-1024B4CE-A719-47A6-AD3A-D4DB8A76DF60Q59586334-7BAF80B3-205D-4E6C-84F9-9A0B284D9738
P50
description
Polish molecular biologist
@en
Pools onderzoeker
@nl
polski biolog molekularny
@pl
name
Janusz A Siedlecki
@ast
Janusz A Siedlecki
@en
Janusz A Siedlecki
@es
Janusz A Siedlecki
@nl
Janusz Siedlecki
@ca
Janusz Siedlecki
@cs
Janusz Siedlecki
@gl
Janusz Siedlecki
@hr
Janusz Siedlecki
@hsb
Janusz Siedlecki
@it
type
label
Janusz A Siedlecki
@ast
Janusz A Siedlecki
@en
Janusz A Siedlecki
@es
Janusz A Siedlecki
@nl
Janusz Siedlecki
@ca
Janusz Siedlecki
@cs
Janusz Siedlecki
@gl
Janusz Siedlecki
@hr
Janusz Siedlecki
@hsb
Janusz Siedlecki
@it
altLabel
Janusz A. Siedlecki
@en
Janusz Aleksander Siedlecki
@en
Janusz Aleksander Siedlecki
@pl
Janusz Siedlecki
@pl
prefLabel
Janusz A Siedlecki
@ast
Janusz A Siedlecki
@en
Janusz A Siedlecki
@es
Janusz A Siedlecki
@nl
Janusz Siedlecki
@ca
Janusz Siedlecki
@cs
Janusz Siedlecki
@gl
Janusz Siedlecki
@hr
Janusz Siedlecki
@hsb
Janusz Siedlecki
@it
P1153
7005899969
P1412
P1559
Janusz Siedlecki
@pl
P21
P27
P31
P3124
P496
0000-0003-4889-5416